USA TODAY on MSN10 天
Everything you need to know about macular degenerationHere's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.
PST-611, a first in class non-viral vectorized therapy expressing human transferrin, a highly potent iron regulator.
2 天
Onlymyhealth on MSNSmoking And Vision Loss: Understanding How It Increases The Risk Of Age-Related Macular ...While the effects of smoking on lungs are widely known, the impact on vision is seldom discussed. Smoking cigarettes can ...
Paul Hahn, MD, PhD, discussed signs and symptoms of age-related macular degeneration (AMD) during AMD Awareness Month.
From cataracts to macular degeneration, discover the 5 leading causes of permanent vision loss and expert-recommended strategies to protect your eyesight.
Charles Smith, who has age-related macular degeneration, has taken part in a series of trials over a 15-year period ...
Although AI shows significant promise in diagnosing and managing age-related macular degeneration, its efficacy is reduced by ...
Imagine a non-invasive, low-risk and cutting-edge therapy that can protect the vision of older adults. For the millions of ...
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...
PST-611 is a first in class non-viral vectorized therapy for the treatment of dry age-related macular degeneration (AMD)/geographic atrophy (GA), expressing human transferrin, a highly potent iron ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果